HEMBROUGH; Todd
Patent Applications and Registrations
Patent applications and USPTO patent grants for HEMBROUGH; Todd.The latest application filed is for "protein expression analysis for breast cancer prognosis and treatment".
Company Profile
36.48.80
- HEMBROUGH; Todd - Gaithersburg MD
- Hembrough; Todd - Culver City CA
- Hembrough; Todd - Gaitherburg MD
- Hembrough; Todd - Damascus MD
Patent Activity
| Patent | Date |
|---|---|
| Protein Expression Analysis For Breast Cancer Prognosis And Treatment App 20200278353 - SCHWARTZ; Sarit ; et al. | 2020-09-03 |
| UCK2 Assay To Predict Cancer Therapy Response App 20200271653 - YAN; Dongyao ; et al. | 2020-08-27 |
| Quantifying MGMT Protein For Optimal Cancer Therapy App 20200271654 - HEMBROUGH; Todd ; et al. | 2020-08-27 |
| Predicting optimal chemotherapy for CRC Grant 10,722,509 - Cecchi , et al. | 2020-07-28 |
| Multiplex MRM assay for evaluation of cancer Grant 10,725,051 - Krizman , et al. | 2020-07-28 |
| Proteomic And Genomic Analysis For Colon Cancer Prognosis App 20200232987 - SCHWARTZ; Sarit ; et al. | 2020-07-23 |
| SRM/MRM assay for the tyrosine-protein kinase receptor UFO(AXL) protein Grant 10,718,780 - Krizman , et al. | 2020-07-21 |
| Quantifying Slfn11 Protein For Optimal Cancer Therapy App 20200171082 - CECCHI; Fabiola ; et al. | 2020-06-04 |
| SRM/MRM Assay for the Tumor Necrosis Factor Receptor Superfamily Member 8 (CD30) Protein App 20200132694 - Krizman; David B. ; et al. | 2020-04-30 |
| SRM/MRM Assays For Notch Pathway Proteins App 20200132696 - HEMBROUGH; Todd ; et al. | 2020-04-30 |
| Methods of treating lung cancer by predicting responders to cisplatin-pemetrexed combination therapy Grant 10,617,717 - Hembrough , et al. | 2020-04-14 |
| SRM/MRM assay for the fibroblast growth factor receptor 2 (FGFR2) protein Grant 10,620,223 - Krizman , et al. | 2020-04-14 |
| SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein Grant 10,620,184 - Krizman , et al. | 2020-04-14 |
| Predicting Cancer Treatment Outcome With T-DM1 App 20200103411 - HEMBROUGH; Todd ; et al. | 2020-04-02 |
| SRM/MRM assays for cancer Grant 10,585,099 - Hembrough , et al. | 2020-03-10 |
| Immune Profiling Of Tumor Tissue App 20200033359 - HEMBROUGH; Todd ; et al. | 2020-01-30 |
| Methods for treating Her2-positive breast cancer Grant 10,537,576 - Blackler , et al. Ja | 2020-01-21 |
| Improved Methods Of Treating Lung Cancer Using Multiplex Proteomic Analysis App 20190353658 - HEMBROUGH; Todd ; et al. | 2019-11-21 |
| Quantifying KRAS for Optimal Cancer Therapy App 20190293652 - CECCHI; Fabiola ; et al. | 2019-09-26 |
| SRM/MRM Assays For CD56 And CHGA Proteins App 20190285647 - HEMBROUGH; Todd ; et al. | 2019-09-19 |
| SRM/MRM Assays for Profiling Tumor Tissue App 20190279771 - HEMBROUGH; Todd ; et al. | 2019-09-12 |
| SRM/MRM Assay For The Tyrosine-Protein Kinase Receptor UFO (AXL) Protein App 20190265252 - Krizman; David B. ; et al. | 2019-08-29 |
| p16 EXPRESSION AND CANCER TREATMENT OUTCOME App 20190219582 - Cecchi; Fabiola ; et al. | 2019-07-18 |
| Predicting Optimal Chemotherapy For CRC App 20190216795 - Cecchi; Fabiola ; et al. | 2019-07-18 |
| SRM/MRM Assay For The Tubulin Beta-3 Chain (TUBB3) Protein App 20190219549 - HEMBROUGH; Todd ; et al. | 2019-07-18 |
| SRM/MRM Assay for the Cyclin-Dependent Kinase Inhibitor 2A (p16) protein App 20190178866 - KRIZMAN; David B. ; et al. | 2019-06-13 |
| Methods For Treating Sarcoma App 20190167628 - THYPARAMBIL; Sheeno ; et al. | 2019-06-06 |
| CMET protein SRM/MRM assay Grant 10,302,656 - Krizman , et al. | 2019-05-28 |
| Quantifying met protein for cancer treatment Grant 10,288,616 - Catenacci , et al. | 2019-05-14 |
| Bcl-2-like protein 11 SRM/MRM assay Grant 10,215,761 - Krizman , et al. Feb | 2019-02-26 |
| SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein App 20190056406 - KRIZMAN; David B. ; et al. | 2019-02-21 |
| Quantifying Her2 protein for optimal cancer therapy Grant 10,208,130 - Bang , et al. Feb | 2019-02-19 |
| SRM/MRM assay for the ephrin type-A receptor 2 protein Grant 10,202,635 - Krizman , et al. Feb | 2019-02-12 |
| SRM/MRM assay for the tyrosine-protein kinase receptor UFO (AXL) protein Grant 10,203,336 - Krizman , et al. Feb | 2019-02-12 |
| Multiplex MRM Assay for Evaluation of Cancer App 20190033320 - Krizman; David B. ; et al. | 2019-01-31 |
| Integrated Analysis To Determine Prognosis After Treatment For Primary Breast Cancer App 20190018017 - Benz; Stephen Charles ; et al. | 2019-01-17 |
| SRM/MRM assay for the androgen receptor (AR) protein Grant 10,126,307 - Krizman , et al. November 13, 2 | 2018-11-13 |
| Multiplex MRM assay for evaluation of cancer Grant 10,101,334 - Krizman , et al. October 16, 2 | 2018-10-16 |
| SRM/MRM assay for the mesothelin (MSLN) protein Grant 10,078,084 - Krizman , et al. September 18, 2 | 2018-09-18 |
| SRM/MRM assay for the cyclin-dependent kinase inhibitor 2A (p16) protein Grant 10,073,075 - Krizman , et al. September 11, 2 | 2018-09-11 |
| SRM/MRM assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein Grant 10,060,927 - Krizman , et al. August 28, 2 | 2018-08-28 |
| Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay Grant 10,054,592 - Krizman , et al. August 21, 2 | 2018-08-21 |
| SRM/MRM assay for the insulin receptor protein Grant 10,041,961 - Krizman , et al. August 7, 2 | 2018-08-07 |
| SRM Assay to Indicate Cancer Therapy App 20180195107 - KRIZMAN; David B. ; et al. | 2018-07-12 |
| SRM/MRM Assays for Cancer App 20180188251 - HEMBROUGH; Todd ; et al. | 2018-07-05 |
| Methods of Treating Lung Cancer by Predicting Responders to Cisplatin-Pemetrexed Combination Therapy App 20180177825 - HEMBROUGH; Todd ; et al. | 2018-06-28 |
| Methods Of Treating Cancer By Identification Of Patients Sensitive To Fgfr Inhibitor Therapy App 20180180628 - Hembrough; Todd ; et al. | 2018-06-28 |
| Method For Improved Hepatocellular Cancer Diagnosis App 20180172690 - RABIZADEH; Shahrooz ; et al. | 2018-06-21 |
| Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM/MRM Assay App 20180136218 - KRIZMAN; David B. ; et al. | 2018-05-17 |
| HER3 protein SRM/MRM assay Grant 9,869,680 - Krizman , et al. January 16, 2 | 2018-01-16 |
| SRM assay to indicate cancer therapy Grant 9,840,728 - Krizman , et al. December 12, 2 | 2017-12-12 |
| SRM/MRM assay for the fatty acid synthase protein Grant 9,804,164 - Krizman , et al. October 31, 2 | 2017-10-31 |
| MRM/SRM assay for death receptor 5 protein Grant 9,804,169 - Krizman , et al. October 31, 2 | 2017-10-31 |
| SRM/MRM assay for subtyping lung histology Grant 9,766,246 - Krizman , et al. September 19, 2 | 2017-09-19 |
| Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay App 20170248608 - KRIZMAN; David B. ; et al. | 2017-08-31 |
| Quantifying FR-.alpha. and GART proteins for optimal cancer therapy Grant 9,746,477 - Hembrough , et al. August 29, 2 | 2017-08-29 |
| Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay Grant 9,733,253 - Krizman , et al. August 15, 2 | 2017-08-15 |
| Methods for treating Her2-positive breast cancer App 20170196869 - BLACKLER; Adele ; et al. | 2017-07-13 |
| SRM/MRM Assays App 20170168055 - Krizman; David ; et al. | 2017-06-15 |
| Srm Assays To Chemotherapy Targets App 20170168057 - KRIZMAN; David B. ; et al. | 2017-06-15 |
| SRM/MRM Assay for the Serine/Threonine-Protein Kinase B-RAF (BRAF) App 20170122953 - Krizman; David B. ; et al. | 2017-05-04 |
| SRM/MRM Assay for the GTPase KRas Protein (KRas) App 20170122946 - Krizman; David B. ; et al. | 2017-05-04 |
| Quantifying Met Protein for Cancer Treatment App 20170097354 - CATENACCI; Daniel ; et al. | 2017-04-06 |
| SRM/MRM Assay for the Androgen Receptor (AR) Protein App 20170052197 - KRIZMAN; David B. ; et al. | 2017-02-23 |
| SRM/MRM Assay for the tyrosine-protein kinase receptor UFO (AXL) protein App 20170052196 - KRIZMAN; David ; et al. | 2017-02-23 |
| Quantifying FR-alpha and GART Proteins for Optimal Cancer Therapy App 20170030923 - HEMBROUGH; Todd ; et al. | 2017-02-02 |
| BCL-2-like protein 11 SRM/MRM assay Grant 9,551,719 - Krizman , et al. January 24, 2 | 2017-01-24 |
| Bcl-2-like Protein 11 Srm/mrm Assay App 20160377633 - KRIZMAN; David ; et al. | 2016-12-29 |
| Quantifying Her2 Protein for Optimal Cancer Therapy App 20160349259 - BANG; Yung-Jue ; et al. | 2016-12-01 |
| Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay App 20160349265 - KRIZMAN; David ; et al. | 2016-12-01 |
| SRM/MRM Assay for the Cyclin-Dependent Kinase Inhibitor 2A (p16) protein App 20160341713 - KRIZMAN; David B. ; et al. | 2016-11-24 |
| SRM/MRM Assay for the Mesothelin (MSLN) protein App 20160334411 - KRIZMAN; David B. ; et al. | 2016-11-17 |
| SRM/MRM Assay for the Fibroblast Growth Factor Receptor 2 (FGFR2) protein App 20160334424 - KRIZMAN; David B. ; et al. | 2016-11-17 |
| SRM/MRM Assay for the 6-O-methylguanine-DNA methyltransferase (MGMT) protein App 20160334408 - KRIZMAN; David B. ; et al. | 2016-11-17 |
| SRM/MRM Assay for Subtyping Lung Histology App 20160320398 - KRIZMAN; David B. ; et al. | 2016-11-03 |
| MRM/SRM Assay for Death Receptor 5 Protein App 20160313344 - KRIZMAN; David ; et al. | 2016-10-27 |
| SRM Assay for PD-L1 App 20160313343 - KRIZMAN; David B. ; et al. | 2016-10-27 |
| SRM/MRM assay for subtyping lung histology Grant 9,470,687 - Krizman , et al. October 18, 2 | 2016-10-18 |
| SRM/MRM assay for the receptor tyrosine-protein kinase erbB-4 protein (HER4) Grant 9,470,696 - Krizman , et al. October 18, 2 | 2016-10-18 |
| Multiplex MRM Assay for Evaluation of Cancer App 20160274124 - KRIZMAN; David B. ; et al. | 2016-09-22 |
| MRM/SRM assay for death receptor 5 protein Grant 9,442,119 - Krizman , et al. September 13, 2 | 2016-09-13 |
| Cmet Protein Srm/mrm Assay App 20160252525 - KRIZMAN; David ; et al. | 2016-09-01 |
| Insulin receptor substrate 1 (IRS1) protein SRM/MRM assay Grant 9,417,246 - Krizman , et al. August 16, 2 | 2016-08-16 |
| SRM/MRM Assay for the Fatty Acid Synthase Protein App 20160216268 - KRIZMAN; David B. ; et al. | 2016-07-28 |
| cMET protein SRM/MRM assay Grant 9,372,195 - Krizman , et al. June 21, 2 | 2016-06-21 |
| Multiplex MRM assay for evaluation of cancer Grant 9,360,487 - Krizman , et al. June 7, 2 | 2016-06-07 |
| SRM/MRM Assay for the Insulin Receptor Protein App 20160131665 - Krizman; David B. ; et al. | 2016-05-12 |
| SRM/MRM assay for the fatty acid synthase protein Grant 9,309,554 - Krizman , et al. April 12, 2 | 2016-04-12 |
| SRM/MRM Assay for Subtyping Lung Histology App 20160054323 - KRIZMAN; David B. ; et al. | 2016-02-25 |
| SRM/MRM assay for subtyping lung histology Grant 9,261,506 - Krizman , et al. February 16, 2 | 2016-02-16 |
| SRM/MRM assay for the insulin receptor protein Grant 9,255,934 - Krizman , et al. February 9, 2 | 2016-02-09 |
| SRM Assay to Indicate Cancer Therapy App 20150376678 - KRIZMAN; David B. ; et al. | 2015-12-31 |
| Her3 Protein Srm/mrm Assay App 20150369818 - KRIZMAN; David ; et al. | 2015-12-24 |
| Her3 protein SRM/MRM assay Grant 9,128,102 - Krizman , et al. September 8, 2 | 2015-09-08 |
| SRM/MRM Assay for Subtyping Lung Histology App 20150072895 - KRIZMAN; David B. ; et al. | 2015-03-12 |
| SRM/MRM Assay for the Ephrin Typa-A Receptor 2 Protein App 20140336281 - Krizman; David B. ; et al. | 2014-11-13 |
| SRM/MRM Assay for the Insulin Receptor Protein App 20140322245 - KRIZMAN; David B. ; et al. | 2014-10-30 |
| SRM/MRM Assay for the Receptor Tyrosine-Protein Kinase erbB-4 Protein (HER4) App 20140213478 - KRIZMAN; David B. ; et al. | 2014-07-31 |
| MRM/SRM Assay for Death Receptor 5 Protein App 20140206776 - KRIZMAN; David B. ; et al. | 2014-07-24 |
| SRM/MRM Assay for the Fatty Acid Synthase Protein App 20140206775 - KRIZMAN; David B. ; et al. | 2014-07-24 |
| Multiplex MRM Assay for Evaluation of Cancer App 20140199717 - KRIZMAN; David B. ; et al. | 2014-07-17 |
| Methods for measuring the level of insulin-like growth factor 1 receptor (IGF1R) protein using SRM/MRM assay Grant 8,728,753 - Krizman , et al. May 20, 2 | 2014-05-20 |
| Cmet Protein Srm/mrm Assay App 20140005282 - Krizman; David ; et al. | 2014-01-02 |
| Bcl-2-like Protein 11 Srm/mrm Assay App 20130302334 - Krizman; David ; et al. | 2013-11-14 |
| Her3 Protein Srm/mrm Assay App 20130289142 - Krizman; David ; et al. | 2013-10-31 |
| Secreted Protein Acidic and Rich in Cysteine (SPARC) Protein SRM Assay App 20130072581 - KRIZMAN; David B. ; et al. | 2013-03-21 |
| Epidermal Growth Factor Receptor (EGFR) Protein SRM Assay App 20130011408 - Krizman; David B. ; et al. | 2013-01-10 |
| Insulin-Like Growth Factor 1 Receptor (IGF1R) Protein SRM/MRM Assay App 20120302650 - Krizman; David B. ; et al. | 2012-11-29 |
| Insulin Receptor Substrate 1 (IRS1) Protein SRM/MRM Assay App 20120295990 - KRIZMAN; David B. ; et al. | 2012-11-22 |
| Compositions and Methods for Inhibiting Cellular Proliferation App 20080090760 - Hembrough; Todd ; et al. | 2008-04-17 |
| Compositions and methods comprising protein activated receptor antagonists App 20060142203 - Hembrough; Todd ; et al. | 2006-06-29 |
| Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments App 20060025329 - Hembrough; Todd ; et al. | 2006-02-02 |
| Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments Grant 6,946,439 - Hembrough , et al. September 20, 2 | 2005-09-20 |
| Compositions and methods comprising protein activated receptor antagonists App 20040266687 - Hembrough, Todd ; et al. | 2004-12-30 |
| Compositions and methods for inhibiting cellular proliferation comprising TFPI fragments App 20020173465 - Hembrough, Todd ; et al. | 2002-11-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 